Blood Urea Nitrogen-to-Albumin Ratio in Critical Care and Acute Illness
This research community investigates the prognostic value of the blood urea nitrogen-to-albumin ratio (BUN/Alb) in predicting mortality and clinical outcomes for patients with acute conditions such as pancreatitis, heart failure, and sepsis.
The work is dominated by retrospective cohort studies and meta-analyses that examine the association between BUN/Alb levels and in-hospital or all-cause mortality. Recurring applications include risk stratification in acute pancreatitis, critically ill patients, acute ischemic stroke, and acute kidney injury. The literature frequently compares BUN/Alb against other biomarkers like creatinine and lactate, often utilizing large databases such as MIMIC-IV. While the primary focus is on the ratio itself, a smaller subset of papers explores the predictive power of related metrics like the urea-to-creatinine ratio in specific contexts such as geriatric emergency care and chronic heart failure exacerbations.
The largest share of the community's output is found in nitrogen research, accounting for 0.1% of all nitrogen research tracked, with 575 papers in this group.
The community comprises 842 papers, publishing most frequently in Medicine, Journal of Clinical Medicine, and Frontiers in Medicine.
Recent work continues to focus on validating BUN/Alb as a predictor of mortality in acute pancreatitis and sepsis-associated delirium, with some studies applying machine learning and deep learning approaches to refine risk prediction models in nephrology and intensive care settings.